Related Experiment Videos
Carbon ions collapse the hypoxic lipid shield to decouple survival from redox vulnerability in NSCLC
Ningyi Ma1, Wei Hu1, Yong Deng2
1Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China; Shanghai Key Laboratory of Radiation Oncology, China; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, China.
Abstract:
Hypoxic non-small cell lung cancer (NSCLC) cells actively remodel lipid metabolism to construct a biochemical shield against lipotoxicity and oxidative stress. This adaptation drives a unidirectional phosphatidylcholine to triacylglycerol conversion with a Z-score of 4.253. While clinically equivalent doses of conventional X-rays (6 Gy) leave the hypoxia-adapted lipidome intact and yield zero significantly altered lipid species, carbon ions radiation markedly rewire the lipidome, significantly displacing 79 lipid species. Combining carbon ions radiation with HIF-1α knockdown amplifies this displacement to 134 altered lipids. This profound structural remodeling is dominated by the exhaustion of phosphatidylcholine and sphingomyelin. Crucially, this metabolic shift occurs without additional acute clonogenic cell kill compared to carbon ions alone. This effectively decouples metabolic disruption from immediate reproductive death. Untargeted metabolomics confirms the concurrent collapse of mitochondrial electron transport and glutathione buffering. Carbon ions radiation effectively abrogate the hypoxic lipid shield. The resulting metabolically compromised survivor subpopulation, stripped of its antioxidant defenses, reveals a pronounced vulnerability to lipid peroxidation. Conventional survival-based relative biological effectiveness systematically underestimates this effect. This study provides defined redox-targeted mechanisms for deploying ferroptosis inducers as precision combination therapies in hypoxic solid tumors.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
The Intrinsic Apoptotic Pathway
Peroxisomes